Article ; Online: Effect of oat supplementation interventions on cardiovascular disease risk markers: a systematic review and meta-analysis of randomized controlled trials.
2022 Volume 61, Issue 4, Page(s) 1749–1778
Abstract: Purpose: Oat supplementation interventions (OSIs) may have a beneficial effect on cardiovascular disease (CVD) risk. However, dietary background can modulate such effect. This systematic review assesses the effects of OSIs on CVD risk markers among ... ...
Abstract | Purpose: Oat supplementation interventions (OSIs) may have a beneficial effect on cardiovascular disease (CVD) risk. However, dietary background can modulate such effect. This systematic review assesses the effects of OSIs on CVD risk markers among adults, accounting for different dietary backgrounds or control arms. Methods: We included randomized clinical trials (RCTs) that assessed the effect of oat, oat beta-glucan-rich extracts or avenanthramides on CVD risk markers. Results: Seventy-four RCTs, including 4937 predominantly hypercholesterolemic, obese subjects, with mild metabolic disturbances, were included in the systematic review. Of these, 59 RCTs contributed to the meta-analyses. Subjects receiving an OSI, compared to control arms without oats, had improved levels of total cholesterol (TC) [weighted mean difference and (95% CI) - 0.42 mmol/L, (- 0.61; - 0.22)], LDL cholesterol [- 0.29 mmol/L, (- 0.37; - 0.20)], glucose [- 0.25 nmol/L, (- 0.36; - 0.14)], body mass index [- 0.13 kg/m Conclusion: Dietary OSIs resulted in lowered levels of blood lipids and improvements in anthropometric parameters among participants with predominantly mild metabolic disturbances, regardless of dietary background or control. Further high-quality trials are warranted to establish the role of OSIs on blood pressure, glucose homeostasis and inflammation markers. |
---|---|
MeSH term(s) | Adult ; Avena ; Biomarkers ; Cardiovascular Diseases/prevention & control ; Cholesterol ; Dietary Supplements ; Glucose ; Humans ; Inflammation ; Randomized Controlled Trials as Topic |
Chemical Substances | Biomarkers ; Cholesterol (97C5T2UQ7J) ; Glucose (IY9XDZ35W2) |
Language | English |
Publishing date | 2022-01-03 |
Publishing country | Germany |
Document type | Journal Article ; Meta-Analysis ; Review ; Systematic Review |
ZDB-ID | 1466536-0 |
ISSN | 1436-6215 ; 1436-6207 |
ISSN (online) | 1436-6215 |
ISSN | 1436-6207 |
DOI | 10.1007/s00394-021-02763-1 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ue I Zs.262: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.